JUVENILE PSORIATIC ARTHRITIS
Clinical trials for JUVENILE PSORIATIC ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new JUVENILE PSORIATIC ARTHRITIS trials appear
Sign up with your email to follow new studies for JUVENILE PSORIATIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with joint pain: risankizumab trial launches
Disease control Recruiting nowThis study tests a drug called risankizumab in children with juvenile psoriatic arthritis, a condition causing joint pain and swelling. About 40 kids will receive either risankizumab or the standard drug adalimumab for 24 weeks, with responders continuing for up to 2 years. The g…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
New hope for kids with arthritis: experimental drug enters final testing phase
Disease control Recruiting nowThis study tests a drug called deucravacitinib in children aged 5 to 17 with active juvenile psoriatic arthritis, a condition causing joint pain and swelling. The trial aims to see if the drug can control the disease and prevent flare-ups. About 60 participants will receive eithe…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New hope for kids with arthritis: drug trial launches
Disease control Recruiting nowThis study tests a drug called bimekizumab in children aged 2 to 17 with specific types of juvenile arthritis (enthesitis-related arthritis and juvenile psoriatic arthritis). The goal is to see how the drug moves through the body and if it is safe. About 40 children will take par…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Kids with gut or joint inflammation get long-term safety check on biologic drug guselkumab
Disease control Recruiting nowThis study is checking the long-term safety of guselkumab, a biologic drug given as a shot, in children with moderate to severe Crohn's disease, ulcerative colitis, or juvenile psoriatic arthritis. About 196 kids who already completed a prior guselkumab study and benefited from i…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New drug trial aims to control arthritis in kids
Disease control Recruiting nowThis study is testing a drug called secukinumab, given as an IV infusion, in 20 children aged 2 to 17 with juvenile psoriatic arthritis. The main goals are to see how the drug moves through the body and to check its safety over up to 6 years. This is an early-stage trial, so it f…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New study checks safety of apremilast for kids with painful mouth sores and arthritis
Disease control Recruiting nowThis study looks at the long-term safety of the drug apremilast in children aged 2 and older with Behçet's disease (causing mouth ulcers) or aged 5 and older with juvenile psoriatic arthritis. About 48 kids who finished a previous study will take apremilast for up to 52 more week…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC